| Hyaluronic Acid in Healthcare (PHM284A) |
| Orthovisc |
|
Orthovisc is a 3- or 4-injection, HA viscosupplement product indicated for pain relief from OA conditions. Labeling in the U.S. limits its use to the knee exclusively, while labeling outside the U.S. is broader, including the knee, shoulder, hip, and ankle. In the U.S., Orthovisc is marketed exclusively by J&J MedTech.
|
| Monovisc |
|
Monovisc is a single-injection, HA viscosupplement product indicated for pain relief from OA conditions. Labeling in the U.S. limits its use to the knee exclusively, while labeling outside the U.S. is broader, including the knee, shoulder, hip, and ankle. In the U.S., Monovisc is marketed exclusively by J&J MedTech.
|
| Cingal |
|
A single-injection OA pain management product. It consists of cross-linked HA material combined with a fast-acting steroid, designed to provide both short- and long-term pain relief. Cingal is CE marked, and it is currently being sold outside the U.S. in over 35 countries.
|
|
